Brief: MGC Pharmaceuticals Receives Permission For First Import Of Psilocybin
31/07/2023 07:40
July 31 (Reuters) - MGC Pharmaceuticals Ltd MXC.AX :
* MGC PHARMACEUTICALS - PERMISSION FOR FIRST IMPORT OF PSILOCYBIN
Source text for Eikon: ID:nRSe6410Ha
Further company coverage: MXC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argent BioPharma
See all newsBrief: Argent Biopharma Enters Long Term Aquiol Licensing And Supply Agreement
Brief: Argent Biopharma Secures A$11M Financing Facility To Complete Strategic Acquisition
Brief: Argent Is Growing Through M&A Projected Merged Company Value Of $100M In Ac8 Asset Acquisition
Australia's Argent BioPharma set for best day in a year on AusCann deal
Brief: Argent Biopharma To Acquire Core Operating Assets And IP Portfolio Of Auscann Group